Back to Search Start Over

Whole-body insulin clearance in people with type 2 diabetes and normal kidney function: Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivity

Authors :
Michaël J.B. van Baar
Erik J.M. van Bommel
Mark M. Smits
Daan J. Touw
Max Nieuwdorp
Reinier W. ten Kate
Jaap A. Joles
Daniël H. van Raalte
Experimental Vascular Medicine
Vascular Medicine
ACS - Diabetes & metabolism
Amsterdam Gastroenterology Endocrinology Metabolism
Pharmaceutical Analysis
Critical care, Anesthesiology, Peri-operative and Emergency medicine (CAPE)
Medicinal Chemistry and Bioanalysis (MCB)
Groningen Research Institute for Asthma and COPD (GRIAC)
Biopharmaceuticals, Discovery, Design and Delivery (BDDD)
Internal medicine
AGEM - Endocrinology, metabolism and nutrition
Source :
Journal of diabetes and its complications, 36(4):108166. Elsevier Inc., JOURNAL OF DIABETES AND ITS COMPLICATIONS, 36(4):108166. ELSEVIER SCIENCE INC, van Baar, M J B, van Bommel, E J M, Smits, M M, Touw, D J, Nieuwdorp, M, ten Kate, R W, Joles, J A & van Raalte, D H 2022, ' Whole-body insulin clearance in people with type 2 diabetes and normal kidney function : Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivity ', Journal of Diabetes and its Complications, vol. 36, no. 4, 108166 . https://doi.org/10.1016/j.jdiacomp.2022.108166, Journal of Diabetes and its Complications, 36(4):108166. Elsevier Inc.
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Abstract

OBJECTIVE: Kidney insulin clearance, proposed to be the main route of extra-hepatic insulin clearance, occurs in tubular cells following glomerular filtration and peritubular uptake, a process that may be impaired in people with type 2 diabetes (T2D) and/or impaired kidney function. Human studies that investigated kidney insulin clearance are limited by the invasive nature of the measurement. Instead, we evaluated relationships between whole-body insulin clearance, and gold-standard measured kidney function and insulin sensitivity in adults with T2D and normal kidney function.RESEARCH DESIGN AND METHODS: We determined insulin, inulin/iohexol and para-aminohippuric acid (PAH) clearances during a hyperinsulinemic-euglycemic clamp to measure whole-body insulin clearance and kidney function. Insulin sensitivity was expressed by glucose infusion rate (M value). Associations between whole-body insulin clearance, kidney function and insulin sensitivity were examined using univariable and multivariable linear regressions models.RESULTS: We investigated 44 predominantly male (77%) T2D adults aged 63 ± 7, with fat mass 34.5 ± 9 kg, lean body mass 63.0 ± 11.8 kg, and HbA1c 7.4 ± 0.6%. Average whole-body insulin clearance was 1188 ± 358 mL/min. Mean GFR was 110 ± 22 mL/min, mean ERPF 565 ± 141 mL/min, and M value averaged 3.9 ± 2.3 mg/min. Whole-body insulin clearance was positively correlated with lean body mass, ERPF and insulin sensitivity, but not with GFR. ERPF explained 6% of the variance when entered in a nested multivariable linear regression model op top of lean body mass (25%) and insulin sensitivity (15%).CONCLUSIONS: In adults with T2D and normal kidney function, whole-body insulin clearance was predicted best by lean body mass and insulin sensitivity, and to a lesser extent by ERPF. GFR was not associated with whole-body insulin clearance. In contrast to prior understanding, this suggests that in this population kidney insulin clearance may not play such a dominant role in whole-body insulin clearance.

Details

ISSN :
10568727
Volume :
36
Database :
OpenAIRE
Journal :
Journal of Diabetes and its Complications
Accession number :
edsair.doi.dedup.....789484750e2e15fc70077d8df0f9922a
Full Text :
https://doi.org/10.1016/j.jdiacomp.2022.108166